Mallinckrodt Puts Off Planned Generics Spinoff Amid Opioid Cases
Mallinckrodt Plc said it would suspend the spinoff of its specialty-generics business as it grapples with a wave of lawsuits related to opioid painkillers and a bruising marketplace for copycat medicines. The company is still considering a range of options …